respectively, and expressed these constructs in six scavenger cells (coelomocytes) in C. elegans ( Fig. 1b and Supplementary Fig. 1) . Focusing initially on the HS4C3 scFv antibody 8 , we found that expression of a secreted HS4C3-GFP fusion produced discrete staining in vivo, predominantly in the nervous system ( Fig. 1c-o) . We did not observe similar staining patterns in worms expressing a negative-control antibody fusion (MPB49-GFP, encoded by MPB49øGFP) that differs from the HS4C3 antibody in five amino acids and has no known epitope 9 (Fig. 1h and Table 1 ). Staining patterns appeared independent of the promoter used to express the scFv-antibody fusion, the fluorescent protein or the extent of transgene expression ( Supplementary Figs. 2-4) . Lastly, the stained structures in the nervous system were distant from the site of antibody expression in the coelomocytes. The in vivo staining patterns of transgenic antibodies overlapped, but were not identical to, immunohistochemical stains of fixed worms that in addition to the nervous system and pharynx included the intestine (Supplementary Fig. 5 ). This suggests that some heparan sulfate may be located in cellular compartments that were inaccessible to the secreted scFv antibody-GFP expressed from transgenes. We conclude that the observed staining patterns were specific for the HS4C3-GFP antibody fusion.
In vitro, the scFv HS4C3 recognizes a heparan sulfate epitope comprising 3-O-sulfated and 6-O-sulfated glucosamine residues with a minor contribution of 2-O-sulfation on hexuronic acid moieties 8 . To determine whether HS4C3-GFP expressed from a transgene recognized heparan sulfate with similar specificity, we removed genes required for heparan sulfate modifications and quantified relative fluorescence, using the prominent nerve ring staining as a proxy (Supplementary Fig. 6a ). Genetic removal of hst-6, which encodes the heparan 6-O-sulfotransferase, or of both genes encoding heparan 3-O-sulfotransferases (hst-3.1 and hst-3.2) reduced nerve-ring staining, whereas individual removal of hst-3.1 or hst-3.2 yielded no reduction in nerve-ring staining ( Fig. 1i-l,p) . This suggested that hst-3.1 and hst-3.2 can act redundantly in forming the heparan sulfate modification pattern recognized by HS4C3-GFP. In contrast, genetic removal of hse-5, which encodes the heparan sulfate C-5 epimerase, or hst-2, which encodes the heparan 2-O-sulfotransferase, increased nerve-ring staining ( Fig. 1m,n,p) . As hst-2 restricts heparan sulfate 6-O-sulfation 10 , its removal increased 6-O-sulfation, which may be sufficient for increased binding or, alternatively, 2-O-sulfation may have an inhibitory effect on binding of HS4C3-GFP. Nerve-ring staining in the hst-6, hst-2 double mutant was significantly reduced compared to the hst-6 single mutant (P = 1.25 × 10 −7 , n = 34; Fig. 1i ,o,p), demonstrating that (i) increased staining in hst-2 mutants was hst-6-dependent and (ii) in the absence of hst-6, HS4C3-GFP staining direct visualization of specifically modified extracellular glycans in living animals
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modification patterns of heparan sulfate coordinate protein function in metazoans, yet in vivo imaging of such non-genetically encoded structures has been impossible. here we report a transgenic method in Caenorhabditis elegans that allows direct live imaging of specific heparan sulfate modification patterns. this experimental approach reveals a dynamic and cell-specific heparan sulfate landscape and could in principle be adapted to visualize and analyze any extracellular molecule in vivo.
Fluorescent protein fusions 1 allow live imaging of virtually every protein. In contrast, in vivo visualization of non-genetically encoded molecules such as glycans or lipids is more challenging. Using 'click' chemistry, some glycans have been visualized in live zebrafish and Caenorhabditis elegans 2,3 , but modifications of the glycans, which are crucial for the function of many molecules, cannot be distinguished. For example, heparan sulfates are extracellular glycosaminoglycans with complex modification patterns ( Fig. 1a ) that are attached to heparan sulfate proteoglycan core proteins such as membrane-associated syndecans and glypicans or the secreted perlecan and agrin 4, 5 . Heparan sulfate modification patterns have pivotal roles in metazoan development and physiology by interacting with and modulating the function of a wide array of proteins 4, 5 . Biochemical studies and the identification of specific neuroanatomical defects of mutants in heparan sulfate genes in vertebrates and invertebrates have led to the 'heparan sulfate code' hypothesis, which posits that distinct heparan sulfate modification patterns are localized in a tissue-or cell-specific pattern, particularly in the nervous system 6 .
We developed an in vivo technique to visualize and analyze complex heparan sulfate modification patterns to directly test this hypothesis. To this end, we made use of a subset of heparan sulfate-specific single chain variable fragment (scFv) antibodies 7 that recognize specifically modified forms of heparan sulfate ( Table 1) . We fused a secretion signal and GFP (GFP(S65T)) to the N terminus and C terminus of heparan sulfate-specific scFv antibodies, brief communications depended on, rather than was inhibited by, the 2-O-sulfotransferase encoded by hst-2 and by inference 2-O-sulfation.
We next tested which heparan sulfate core protein(s) bears the heparan sulfate epitope recognized by HS4C3-GFP. Removal of the single C. elegans syndecan (sdn-1), but not the two glypicans (gpn-1 or lon-2), perlecan (unc-52) or agrin (agr-1), eliminated staining of the nerve ring as well as of the nerve cords, indicating that the majority of heparan sulfate recognized by HS4C3-GFP is associated with the nervous system and attached to the syndecan core protein ( Fig. 1q and Supplementary Fig. 6b-g) . Increased nervering staining upon loss of gpn-1 was sdn-1-dependent ( Fig. 1q and Supplementary Fig. 6b ,c,f), possibly owing to compensatory mechanisms. Staining of structures outside of the nerve ring was reduced in strains lacking sdn-1 (Supplementary Fig. 6c ,f), consistent with the interpretation that HS4C3-GFP recognized other heparan sulfate epitopes attached to syndecan with possibly lower affinity. The differences in staining in heparan sulfate mutants were neither due to changes in transgene expression ( Supplementary  Fig. 7 ) nor the permeability of basement membranes as a result of an altered charge distribution 11 . First, the distribution of the MPB49-GFP control antibody fusion was unaffected in heparan sulfate mutant backgrounds, and second, different heparan sulfate-specific antibody-GFP fusions had distinct specificities compared to HS4C3-GFP ( Table 1 and Supplementary Figs. 8 and 9) . Thus, HS4C3-GFP recognized a heparan sulfate modification pattern in vivo that is borne by the syndecan core protein, and consistent with in vitro binding studies of HS4C3 (ref. To study the dynamics and diversity of heparan sulfate modification patterns in vivo, we analyzed worms expressing HS4C3-GFP and several additional heparan sulfate-specific scFv-antibody fusions with different binding characteristics, including HS3A8-GFP, AO4B08-GFP and EW3G6-GFP ( Table 1 and Supplementary Fig. 9 ). HS4C3-GFP staining was associated specifically but not exclusively with the nervous system from the embryonic threefold stage through larval stages into adult stages ( Fig. 2a-g and Supplementary Fig. 10 ). The nerve ring, which forms the major neuropil in the worm, appeared diffusely stained, whereas staining of the dorsal and ventral nerve cords appeared more punctate and of approximately equal intensity ( Fig. 2g) . Thus, heparan sulfate may be associated with motor neuron processes that are present in roughly equal numbers in the dorsal and ventral cords. During later larval stages, we observed discrete staining of the vulval epithelium and uterine tissues ( Fig. 2f) . By late larval stages, we detected additional staining of the basement membranes that surround the body-wall muscles and the anterior and posterior bulbs of the pharynx (Fig. 2c,e,g) . We do not know whether as a secreted molecule heparan sulfate is expressed by the stained tissues or produced by surrounding tissues.
We found staining by the HS3A8-GFP fusion to be very similar, yet stronger than by HS4C3-GFP ( Fig. 2h) . As in vivo binding characteristics of HS3A8 and HS4C3 were distinct and staining of both antibody fusions showed incomplete overlap ( Table 1 and Supplementary Figs. 9 and 11) , we suggest that HS4C3 recognizes a heparan sulfate modification pattern that partially overlaps 
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Glucuronic acid npg with the epitope recognized by HS3A8. Similarly, the AO4B08-GFP fusion labeled the nerve ring and the nerve cords in a both overlapping and distinct fashion. The nerve ring displayed more discrete, sheath-like staining in close apposition to the pharynx, rather than the diffuse staining seen with the HS4C3-GFP fusion (Fig. 2i) . This staining could be associated with the sheath-like extensions of the GLR cells or the muscle plate that wraps around the pharynx 12 . EW3G6-superfolder GFP (2xsfGFP) did not label body wall muscles, but stained exclusively part of the neurites, although not cell bodies of what appeared to be a single pair of neurons. This suggests the existence of unique and cell-specific heparan sulfate modification patterns in the nervous system that are localized to defined subcellular structures (Fig. 2j) . We also detected differences in staining outside of the nervous system ( Fig. 2i and Supplementary Fig. 12 ). We conclude that individual cells can express cell-specific heparan sulfate modification patterns that are associated with defined subcellular structures and dynamically remodeled during development.
Whereas the C. elegans system can take advantage of coelomocytes to remove unbound antibody fusions, transgenic approaches in other genetic models could use inducible systems to limit antibody production. The transgenic expression of scFv antibody-GFP fusions has several unique features. First, although here shown for heparan sulfate, this approach should in principle be applicable to live imaging of any molecule such as glycans or lipids as well as proteins undergoing post-translational modification through phosphorylation, sulfation, acetylation or glycosylation as long as specific scFv antibodies exist. Second, it renders non-genetically encoded molecules amenable to genetic analysis to probe their biosynthesis and, possibly, function. Whereas we did not observe obvious defects in transgenic worms, our method could conceivably combine visualization with functional interference if the antibody fragment had the ability to functionally neutralize its epitope, as has been shown in cell culture experiments 13 . Last, it should allow studies of dynamics of such molecules in vivo, including live fourdimensional imaging of remodeling and, possibly, turnover. Our technique potentially allows development of in vivo biosensors for essentially any molecule and would expand the toolbox for in vivo visualization and analysis of molecules in living animals. npg online methods Strains. Worms were cultured as previously described 17 .
The following strains and alleles (strain designations in parentheses) were used: N2 Bristol wild type, hse-5(tm472) (OH1487), hst-2(ok595) (OH1876), hst-6(ok273) (OH1421), hst-3.1(tm734) (EB649), hst-3.2(tm3006) (EB650), sdn-1(zh20), gpn-1(ok377), lon-2(e678), unc-52(e998), agr-1 (tm2051), unc-104(rh43), otIs76 mgIs18 (OH904), dzEx195 (Punc-122øHS4C3øGFP(S65T); rol-6(su1006)) (EB313), dzEx341 (Punc-122øHS3A8øGFP(S65T); rol-6(su1006)) (EB569), dzEx369 (Punc-122øAO4B08øGFP(S65T); rol-6(su1006)) (EB637), dzEx475 (Punc-122øEW3G6ø2xsfGFP; rol-6(su1006)) (EB917), dzEx206 (Punc-122øMPB49øGFP(S65T); rol-6(su1006)) (EB324), dzIs10V (Punc-122øHS4C3øGFP(S65T); rol-6(su1006)) (EB502), dzIs13 (Punc-122øHS3A8øGFP(S65T); rol-6(su1006)) (EB667), dzIs14 (Punc-122øAO4B08øGFP(S65T); rol-6(su1006)) (EB668), dzIs16 (Puncø122øMPB49øGFP(S65T)) (EB703), otIs173III (Prgef-1øDsRed2; Pttx-3øGFP) 18 . Heparan sulfate mutant strains were crossed into antibody-expressing strains using standard procedures. Details for genotyping are available on request.
To create transgenic worms, single chain variable fragment (scFv) antibody constructs were injected with pRF4 (rol-6(su1006)) as a dominant injection marker at 25 ng/µl and 100 ng/µl, respectively. Several transgenic lines giving comparable results were obtained for each construct. Transgenic lines dzEx195, dzEx341, dzEx369 and dzEx206 were integrated to yield dzIs10V, dzIs13, dzIs14 and dzIs16, respectively. All mutants and integrated transgenes were backcrossed at least four times before analysis. scFvøGFP constructs. scFv antibodies that bind different heparan sulfate preparations were originally isolated from a phage display library 19 . The antibodies comprise different variable heavy chains as indicated ( Table 1 ) and an invariant variable light chain 19 . To assemble the transgenic antibody expression constructs, we used the following general scheme. Sequences of the invariable light chain and each published variable heavy chain were optimized for C. elegans codon usage and synthesized de novo by Entelechon. The scFv heavy chains were then assembled with the invariable light chain using a set of unique restriction sites (Supplementary Fig. 1 ). Subsequently, sequences encoding the scFv antibodies were cloned using SalI and AgeI into pJF33 (Pmyo-3øsecGFP(S65T)) 20 to yield a fusion protein in which the scFv antibody is N-terminally fused in frame to the SEL-1 signal sequence 21 and C-terminally to GFP(S65T) ( Supplementary  Fig. 1) . Sequences encoding scFv constructs with the same heavy chain but differing in the CDR3 region (EW3G6 and HS3A8) were built by PCR-mediated mutagenesis using a Quickchange kit (Stratagene) using the primers 5′-TATTATTGTGCCAGAGG AGGAACCACCCGCATCCGCAAGTGGGGACAGGGAACA-3′ and 5′-TGTTCCCTGTCCCCACTTGCGGATGCGGGTGGTT CCTCCTCTGGCACAATAATA-3′ for EW3G6, and 5′-TATTA TTGTGCCAGAGGAATGCGTCCACGCCTTTGGGGACAG GGAACA and 5′-TGTTCCCTGTCCCCAAAGGCGTGGACG CATTCCTCTGGCACAATAATA-3′ for HS3A8. The completed scFv antibody cassettes were subcloned under the control of the coelomocyte-specific unc-122 promoter 22 or glo-1 promoter 23 . The EW3G6 scFv sequence was fused with sequence encoding two consecutive sfGFP (superfolder GFP) molecules (2xsfGFP) using an established PCR fusion technique 24 and cloned under control of the unc-122 promoter. All sequences that were synthesized de novo or underwent PCR amplification were verified by sequencing and are available upon request.
Fluorometric and microscopic analyses. For quantitative epifluorescence microscopy, worms were synchronized by hypochlorite bleaching and plated on regular nematode plates with OP50 Escherichia coli. Approximately 24 h later, worms were washed off in M9, anesthetized with 1 mM levamisole, mounted on a 5% agarose pad and analyzed on an AxioImagerZ1 compound microscope (Zeiss) or a Leica SP2 AOBS confocal microscope. All images used for quantification were taken with an exposure time of 250 ms at 400× magnification and fluorimetrically analyzed using Zeiss AxioVision software version 4.8 as follows. Relative pixel intensity in a region of 'specific fluorescence' around the nerve ring was measured and divided by the relative pixel intensity measured in a region of 'total fluorescence' comprising the whole head to the posterior end of the pharynx ( Supplementary  Fig. 6 ) to yield relative fluorescence. Care was taken to exclude fluorescing coelomocytes from this quantification, although this was not possible in a few select cases owing to coelomocyte migration defects (for example, some sdn-1 mutant worms). As this did not obviously affect total head fluorescence ( Supplementary  Fig. 7) , which served as the denominator, we included these values in the calculations of relative fluorescence. Statistical significance was calculated using the two-tailed Student's t-test with the Bonferroni correction where applicable.
Microscopic images were acquired with an AxioCam MRm camera mounted on an AxioImager Z1 compound microscope using Axiovision 4.8 Zeiss proprietary software. For preparation of figures we exported images from Axiovision 4.8 by applying a 5% bestfit gamma curve. Some worms were optically sectioned using the Zeiss Apotome on an AxioImager Z1 or a Leica SP2 AOBS confocal microscope. Optical sections were processed as 12-bit grayscale images using Zeiss Axiovision software 4.8 (if obtained with the Apotome) or as 8-bit grayscale images using ImageJ (if obtained with the Leica confocal) to produce maximum intensity projections. All images were assembled into figures using Adobe Photoshop and Adobe Illustrator.
